Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults
Clinical trial NCT01228383 · COMPLETED
Trial details
- NCT number
- NCT01228383
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-10-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.